Viewing Study NCT05347992


Ignite Creation Date: 2025-12-24 @ 3:17 PM
Ignite Modification Date: 2025-12-25 @ 11:26 PM
Study NCT ID: NCT05347992
Status: COMPLETED
Last Update Posted: 2025-01-07
First Post: 2022-04-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ELEVATE - (Empower Lupus Erythematosus Patients Via Allowing RemoTe Evaluation)
Sponsor: DxTerity Diagnostics
Organization:

Study Overview

Official Title: ELEVATE - (Empower Lupus Erythematosus Patients Via Allowing RemoTe Evaluation)
Status: COMPLETED
Status Verified Date: 2025-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ELEVATE
Brief Summary: To explore the potential for use of DxTerity's AIP IFN-1 test as personalized guided care and monitoring module in patients with Systemic lupus erythematosus(SLE) using consented patient health information
Detailed Description: Explore and demonstrate concordance between self-collected samples and traditional phlebotomist venous draw for DxTerity AIP module and biomarkers like C3, C4, anti dsDNA and CRP in SLE participants with self-reported outcomes and medical record data.

The study will collect blood samples and self-reported information for SLE subjects, up to 5000 participants in Phase I, with a subset of 1000 continuing to Phase II with Medical records. Study participants will be recruited using a combination of digital media (including social media, advertising, bloggers, emails). Enrollment and qualification will be done along with consented retrieval of medical records using a study specific mobile app.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: